We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Urine Sample Collection Tubes Relaunched for Microbial Diagnostics

By LabMedica International staff writers
Posted on 02 Dec 2015
A next-generation urine sample collection tube contains an innovative additive that effectively stabilizes bacterial count for up to 48 hours at room temperature, enabling more reliable clinical diagnosis and research.

The medical threshold for diagnosing a urinary tract infection (UTI) is ≥105 CFU/mL. More...
Accurate determination of bacteria count at or very near urine sampling is critical for correct diagnosis. However, rapid bacterial growth in urine samples can lead to false positive results, which would lead to patients taking antibiotics unnecessarily.

The new VACUETTE Urine CCM tube from Greiner Bio-One International GmbH (Kremsmünster, Austria) was introduced in 2014 and is now being relaunched as particularly suitable for microbiological diagnostics and research. The tube contains a highly soluble powder that quickly impedes bacterial growth upon simple thorough mixing with urine sample via only a few inversions of the tube. The sample remains stable with no need for refrigeration – up to 48 hours when stored at 20–25 °C.

Another advantage of the VACUETTE Urine CCM tube is its easy-to-open safety cap that allows for hygienic opening and working conditions – without risk of splashes as may occur with standard rubber stoppers. Plus, the tube is shatterproof and made from highly transparent PET plastic.

A large number of obligatory and optional pathogenic urogenital bacteria can be stabilized in the VACUETTE Urine CCM tube for reliable detection up to 48 hours. UTIs are most commonly caused by Escherichia coli or Staphylococcus spp. In addition to these two bacteria, internal GBO studies have verified the stabilization of Salmonella enteritidis, Candida albicans, and Enterococcus faecalis, and that even certain sensitive microorganisms, such as Streptococcus spp., are stabilized sufficiently.

Related Links:

Greiner Bio-One International GmbH



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.